Patients with drug resistant forms of breast cancer and some forms of pancreatic cancer may have new hope, thanks to a new drug first developed at Griffith and now being trialled in the Czech Republic.
Ground-breaking research from Griffith University on the Gold Coast has some scientists wondering if the entire study of cellular biology needs to be adjusted.
There is new hope in the fight against resistant forms of breast cancer as Griffith Health Institute (GHI) research aims to target the disease with novel anti-cancer agents. Breast cancer occurs when abnormal cells in the breast grow in an uncontrolled way. In 2009, breast cancer was the most common cancer in Australian women (excluding nonmelanoma skin cancer), […]
Griffith's cancer research has been acknowledged as among the best in the state by Cancer Council Queensland and rewarded with significant funding.